227025-33-4Relevant academic research and scientific papers
Use of heterocyclic amine-type compounds as neuroprotective agents
-
, (2008/06/13)
The present invention provides the use of heterocyclic amine-type compounds to prevent or reduce neuronal damages in patients afflicted with or susceptible to disease states or conditions known to result in or cause neuronal damage.
Compounds for treating fibromyalgia and chronic fatigue syndrome
-
, (2008/06/13)
The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of heterocyclic amine-type compounds, substituted phenylazacycloalkane-type compounds, or cabergoline-type compounds, or a salt of any said compound.
Method of treating sexual disturbances
-
, (2008/06/13)
The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) in a dosage range where the sexually therapeutic amount is from about 0.2 thru 8 mg/person/dose and where the sexually mating amount is from about 0.003 thru 0.2 mg/kg/dose.
Treatments for restless legs syndrome
-
, (2008/06/13)
The invention provides methods and use of heterocyclic amines, and phenylazacycloalkane compounds, and their pharmacologically acceptable salts for the treatment of Restless Legs Syndrome (RLS).
(5R)-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione
-
, (2008/06/13)
The present invention is a novel pharmaceutical agent, (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione 1and pharmaceutically acceptable salts thereof.
Process to prepare (5R)-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]-quinolin-2(1h)-one
-
, (2008/06/13)
The present invention is an improved prosess to prepare (5R)-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one the compound of formula (VII).
